These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31865186)

  • 1. Differential leukocyte count is associated with clinical phenotype in Parkinson's disease.
    Umehara T; Oka H; Nakahara A; Matsuno H; Murakami H
    J Neurol Sci; 2020 Feb; 409():116638. PubMed ID: 31865186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral immune profile in drug-naïve dementia with Lewy bodies.
    Umehara T; Mimori M; Kokubu T; Ozawa M; Shiraishi T; Sato T; Onda A; Matsuno H; Omoto S; Sengoku R; Murakami H; Oka H; Iguchi Y
    J Neurol; 2024 Jul; 271(7):4146-4157. PubMed ID: 38581545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson's disease subtypes.
    Ataç Uçar C; Gökçe Çokal B; Ünal Artık HA; İnan LE; Yoldaş TK
    Neurol Sci; 2017 Feb; 38(2):287-293. PubMed ID: 27837368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood inflammatory markers in early Parkinson's disease.
    Kim R; Kim HJ; Kim A; Jang M; Kim A; Kim Y; Yoo D; Im JH; Choi JH; Jeon B
    J Clin Neurosci; 2018 Dec; 58():30-33. PubMed ID: 30454693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study.
    Furuncuoğlu Y; Tulgar S; Dogan AN; Cakar S; Tulgar YK; Cakiroglu B
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1300-6. PubMed ID: 27097950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease.
    Jensen MP; Jacobs BM; Dobson R; Bandres-Ciga S; Blauwendraat C; Schrag A; Noyce AJ;
    Ann Neurol; 2021 Apr; 89(4):803-812. PubMed ID: 33527442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo and Ex Vivo Inflammatory Markers of Common Metabolic Phenotypes in Humans.
    Mærkedahl RB; Frøkiær H; Stenbæk MG; Nielsen CB; Lind MV; Lundtoft C; Bohr MB; Ibrügger S; Metzdorff SB; Vestergaard H; Pedersen O; Lauritzen L
    Metab Syndr Relat Disord; 2018 Feb; 16(1):29-39. PubMed ID: 29319419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease.
    Zhang Z; Wang Y; Wang J; Cai Y; Liu P; Liu S; Wu J; Xie X
    Parkinsonism Relat Disord; 2024 Jun; 123():106102. PubMed ID: 38507892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.
    Rocha NP; Assis F; Scalzo PL; Vieira ÉLM; Barbosa IG; de Souza MS; Christo PP; Reis HJ; Teixeira AL
    Mol Neurobiol; 2018 Feb; 55(2):1488-1497. PubMed ID: 28176275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    Wojtala J; Heber IA; Neuser P; Heller J; Kalbe E; Rehberg SP; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Dodel R; Schulz JB; Reetz K
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):171-179. PubMed ID: 30297519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease.
    Bagheri V; Khorramdelazad H; Hassanshahi G; Moghadam-Ahmadi A; Vakilian A
    Neuroimmunomodulation; 2018; 25(4):201-205. PubMed ID: 30428473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K
    Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.
    Smith AM; Depp C; Ryan BJ; Johnston GI; Alegre-Abarrategui J; Evetts S; Rolinski M; Baig F; Ruffmann C; Simon AK; Hu MTM; Wade-Martins R
    Mov Disord; 2018 Oct; 33(10):1580-1590. PubMed ID: 30294923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
    Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
    J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Blood Monocyte Functions in Parkinson's Disease.
    Nissen SK; Shrivastava K; Schulte C; Otzen DE; Goldeck D; Berg D; Møller HJ; Maetzler W; Romero-Ramos M
    Mov Disord; 2019 Nov; 34(11):1711-1721. PubMed ID: 31449711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma VCAM1 levels correlate with disease severity in Parkinson's disease.
    Perner C; Perner F; Gaur N; Zimmermann S; Witte OW; Heidel FH; Grosskreutz J; Prell T
    J Neuroinflammation; 2019 May; 16(1):94. PubMed ID: 31068198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis.
    Glezeva N; Voon V; Watson C; Horgan S; McDonald K; Ledwidge M; Baugh J
    J Card Fail; 2015 Feb; 21(2):167-77. PubMed ID: 25459685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.
    Yamamoto E; Sugiyama S; Hirata Y; Tokitsu T; Tabata N; Fujisue K; Sugamura K; Sakamoto K; Tsujita K; Matsumura T; Kaikita K; Hokimoto S
    Atherosclerosis; 2016 Dec; 255():210-216. PubMed ID: 27612676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.